Saliva test for heart failure diagnosis
Part of Heart & circulation clinical trials.
This study tests whether a simple saliva sample can detect certain molecules (lncRNAs) that might help diagnose heart failure. It looks at two types of heart failure: chronic stable heart failure and acute decompensated heart failure, and compares them to people without heart failure who are having a heart procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have either chronic stable heart failure (CHF) or acute decompensated heart failure (ADHF).
- If you have CHF, you have symptoms that limit activity (NYHA class II, III, or IV) and a specific blood test (NT-proBNP) level that matches your heart's pumping strength.
- If you have ADHF, you have symptoms (like shortness of breath or leg swelling) and meet certain blood test or physical exam criteria.
- You are not pregnant, do not have cardiac amyloidosis, and do not have an active cancer.
- You are not currently breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
This trial tests a new device called V-Lap that is placed in the heart to monitor pressure. It may help doctors better manage heart failure and reduce hospital stays. Researchers want to see if it works well in people with mild to moderate heart failure.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
This study looks at whether doing very detailed heart testing helps understand and guide care for people with heart failure with preserved pumping strength. You may be eligible if you’re an adult with specific symptom levels, recent heart-failure-related visits, and matching scan and blood test results.
This study tests whether a small wireless sensor can safely measure and track pressure in the left upper heart chamber in people with advanced chronic heart failure. It may help the care team better understand pressure changes that are linked to fluid buildup and symptoms, alongside your usual heart medicines.
Hear when a new CHF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.